For a study, researchers sought to determine the scales used in the diagnosis of incontinence-associated dermatitis (IAD), including the risk variables included in the scales, their reliability and validity, and which patient groups the scales were used on.

The studies were retrospectively screened using various combinations of five MeSH (Medical Subject Headings) keywords. Between March and July of this year, seven overseas databases were reviewed. There were 2,908 studies examined in all, published between 2009 and 2019. The research has to be written in English, published between 2009 and 2019, and study a scale created to diagnose IAD (quantitative studies, randomized controlled studies, or meta-analyses). Studies that did not explore measures for diagnosing IAD or were not in English were omitted. The review covered 9 studies: five on scale formulation, one on scale revision, one on scale reliability, and two on Turkish validity and reliability. The study methodology, sample characteristics, interventions, validity and reliability analyses, risk factors in the scales, and scale subdimensions were assessed for each of the nine included investigations.

The study samples ranged in size from 9 to 823 participants and included nurses, healthcare workers, patients, or nursing home residents. The majority of the information was gathered via hospital-wide clinics. Redness, rash, skin loss, incontinence type, infection symptoms, skin color, edema, patient experience, discomfort, and perineal care behaviors were all assessed using scales. In eight of the investigations, both the validity and reliability of the scales were tested; in one study, only the reliability was studied because the scale validity had already been demonstrated. Furthermore, sensitivity and specificity were found in one investigation.

Various competent scales with demonstrated validity and reliability in the literature may be used to diagnose IAD.